Use of hyaluronic acid to repair ischemia reperfusion damage

Details Use of hyaluronic acid to repair ischemia reperfusion damage Use of hyaluronic acid to repair ischemia reperfusion damage

1994-02-23

1997-10-07

Peselev, Elli

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

536 551, A61K 3170

Patent

active

056748574

ABSTRACT:
A pharmaceutical composition comprising an effective non-toxic amount of hyaluronic acid (HA) and or salts thereof and/or homologues, analogues, derivatives, complexes, esters, fragments and units of HA in association with a suitable diluent or pharmaceutically acceptable carrier for use in treating ischemia damage in tissue.

REFERENCES:
patent: 4141973 (1979-02-01), Balazs
patent: 4303676 (1981-12-01), Balazs
patent: 4582865 (1986-04-01), Balazs et al.
patent: 4636524 (1987-01-01), Balazs et al.
patent: 4684627 (1987-08-01), LeVeen et al.
patent: 4711780 (1987-12-01), Fahim
patent: 4713448 (1987-12-01), Balazs et al.
patent: 4719201 (1988-01-01), Foker
patent: 4725585 (1988-02-01), Wenge et al.
patent: 4736024 (1988-04-01), Della Valle et al.
patent: 4755544 (1988-07-01), Makino et al.
patent: 4782046 (1988-11-01), Brown et al.
patent: 4784990 (1988-11-01), Nimrod et al.
patent: 4795741 (1989-01-01), Leshchiner et al.
patent: 4801619 (1989-01-01), Lindbland
patent: 4806567 (1989-02-01), Ferrari et al.
patent: 4808576 (1989-02-01), Schultz et al.
patent: 4814176 (1989-03-01), Makino et al.
patent: 4840941 (1989-06-01), Ueno et al.
patent: 4851521 (1989-07-01), della Valle et al.
patent: 4931460 (1990-06-01), Grover et al.
patent: 4937254 (1990-06-01), Sheffield et al.
patent: 4957744 (1990-09-01), della Valle et al.
patent: 4965353 (1990-10-01), della Valle et al.
patent: 4968671 (1990-11-01), Asano et al.
patent: 4970298 (1990-11-01), Silver et al.
patent: 4988515 (1991-01-01), Buckberg
patent: 5057494 (1991-10-01), Sheffield
patent: 5095027 (1992-03-01), Goldberg et al.
patent: 5095037 (1992-03-01), Iwamitsu et al.
patent: 5099012 (1992-03-01), Wu et al.
patent: 5166331 (1992-11-01), Fidia
U.S. application No. 07/338,106, Falk, Filed Apr. 4, 1989.
Sandra Blakeslee, "Solid cores of tumors keeping out best drugs", Jul. 8, 1989 edition of the Globe and Mail, Toronto, Ontario, p. D4.
Pam Harrison, "Toxic drug tamed by still potent" Ontario Medicine, vol. 8, No. 16 dated Aug. 21, 1989, p. 1.
The Merck Index Eleventh Edition, Centennial Edition, Hyaluronic Acid formulation, pp. 751 and 752.
Alan R. Liss, Inc., Modulation of Immunity in Cancer Patients by Prostaglandin Antagonists, Immunity to Cancer II.
Goodwin, J.S. Prostaglandin E and Cancer Growth Potential for Immunotherapy with Prostaglandin Synthesis Inhibitors, Augmentive Agents in Cancer Therapy, Raven Press, New York, (1981).
Dr. Samuel Asculai, "Inactivation of Herpes Simplex Viruses by Nonionic Surfactants", Antimicrobial Agents and Chemotherapy, Apr. 1978, pp. 686-690.
Chemical Abstracts, vol. 76, No. 10; W. E. Sneader; "Possible Mechanism for action of DMSO on Percutaneous absorption", J. Pharm. Pharmcol., 1971, 23 (Supp).

Affiliated with

Also associated with

Rating

Use of hyaluronic acid to repair ischemia reperfusion damage does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of hyaluronic acid to repair ischemia reperfusion damage, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of hyaluronic acid to repair ischemia reperfusion damage will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2357497